LexDanaLexDanabeta
Inventor

JAG PAUL HEER

Inventor
GB

Overview

3→
Patents
2024–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
C07DHeterocyclic compounds38%
A61KPreparations for medical, dental or toiletry purposes13%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium13%
PatentTitleYear
12,577,228Dihydrocyclopenta-isoquinoline-sulfonamide derivatives compounds202612,410,161Tetrahydrobenzo-quinoline sulfonamides derivative compounds202511,912,721Fused pentacyclic imidazole derivatives2024

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2024–2026Patents assigned to UCB Biopharma SRL (3)· patent assignee history
2024Patents assigned to SANOFI SA (1)· patent assignee history
2024–2026Based in GB· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
UCB Biopharma SRL32024–2026
SANOFI SA12024
Locations
LocationPatentsSpan
GB32024–2026